SANGITA DESAI: Open Payments
NPI 1386795532 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 34 payments from 8 companies in 2025. Trend: 2023 $525 · 2024 $757 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $331 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $239 |
| ABBVIE INC. | 4 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, COBENFY, AUSTEDO XR, INVEGA, Qelbree, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
